SecBot SecBot
ANALYST-UPGRADE ·Filed Jul 21, 2026

INSM

INSMED Inc
BULLISH
Impact 4/10
Horizonmonths Processed3mo ago SECanalyst-INSM-bmocapit-20260721
BMO Capital initiates coverage on INSM at Outperform
Actionable Insight ▲ Bullish

BMO's initiation adds another bullish voice to an already crowded long consensus, but the heavy insider selling and negative EPS revision trend warrant caution. Traders should watch for a catalyst to close the gap between the $107 price and the ~$196 mean target, but avoid chasing into insider distribution.

DirectionBullish
Confidencemedium
Horizonmonths

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$108.62
T+0 close · Jul 21, 2026 · via day close
Latest settled
−10.89%
T+60 · $96.79
Vs SPY
−14.86%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 21 $108.62entry
  2. T+1 · 4mo ago −1.82%α −1.71% · $106.64
  3. T+5 · 4mo ago −3.58%α −2.35% · $104.73
  4. T+20 · 3mo ago +18.27%α +15.70% · $128.46
  5. T+60 · 5w ago −10.89%α −14.86% · $96.79
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

BMO Capital initiated coverage on INSM at Outperform with a $192 price target, implying 78.6% upside from the current $107.56. The firm has a 53% accuracy rate on 1,842 calls with a 2.3% average return, placing it in the middle tier among firms covering INSM. Consensus is overwhelmingly bullish, 28 of 29 analysts rate Buy or Strong Buy, with only 1 Hold and zero Sell ratings. The mean price target is $196.38, median $200, high $243, low $140. BMO's $192 target is slightly below the mean but still well above current levels. Momentum is positive: 1 upgrade and 0 downgrades in the last 30 days, though EPS revisions for the current fiscal year show 4 downward revisions vs 0 upward. Insider selling is notable, two C-suite members sold over $2.6M in July, but institutional buying is strong, with several funds adding or doubling positions. The initiation from a mid-tier firm adds modest bullish confirmation to an already crowded long consensus.

Impact Score

Base Score
2/7
LLM Adjustment
+1
Final Score
4/10

Consensus & Targets

Buy / Strong Buy
28 (97%)
Hold
1
Sell / Strong Sell
0
Total Analysts
21
Mean PT
$196.38
Median PT
$200.00
High PT
$243.00
Low PT
$140.00
Current Price
$107.56
Implied Upside
+82.6%

Consensus is 28 Buy/Strong Buy (97%), 1 Hold (3%), 0 Sell/Strong Sell. 29 analysts cover the stock. Direction is strongly bullish, with only one hold rating.

Mean PT $196.38, median $200, high $243, low $140. Current price $107.56 implies 82.6% upside to the mean. BMO's $192 PT is 2.2% below the mean, in line with the bullish consensus.

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-07-21BMO CapitalinitiateOutperform$192.00
2026-07-15Wells FargomaintainOverweight$161.00
2026-07-10GuggenheimreiterateBuy$207.00
2026-06-22Evercore ISI GroupmaintainOutperform$160.00
2026-06-08JP MorganmaintainOverweight$179.00
2026-06-05RBC CapitalmaintainOutperform$195.00
2026-05-14Truist SecuritiesmaintainBuy$185.00
2026-05-08RBC CapitalmaintainOutperform$205.00
2026-05-08Wells FargomaintainOverweight$160.00
2026-05-08GuggenheimmaintainBuy$226.00

30-day analyst activity: 1 upgrade (this initiation), 0 downgrades. EPS revisions: current quarter (0q) had 1 up and 1 down revision in 30 days, neutral. Current fiscal year (0y) had 0 up and 4 down revisions. Next fiscal year (+1y) had 2 up and 3 down revisions. Net revision trend is slightly negative.

Firm Track Record: BMO Capital

BMO Capital accuracy: 53% on 1842 calls | avg return: 2.3%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
Barclays100%2/2106.1%top tier
Jefferies100%2/271.2%top tier
B of A Securities75%6/823.2%top tier
JP Morgan71%5/724.8%top tier
Truist Securities70%7/1054.4%top tier
Wells Fargo67%6/937.2%top tier
Mizuho67%4/646.5%top tier
HC Wainwright & Co.64%9/1431.2%top tier
UBS63%5/827.6%top tier
Morgan Stanley63%5/854.8%top tier

BMO Capital has a 53% accuracy rate on 1,842 scored calls with a 2.3% average return, middle tier among firms covering INSM. Top-tier firms by accuracy on this stock include Barclays (100% on 2 calls), Jefferies (100% on 2), and BofA (75% on 8). Bottom-tier: Cantor Fitzgerald (40% on 5, -9.8% avg return) and TD Cowen (33% on 6, -0.4% avg return).

Earnings Estimates

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
0q$-0.69$-1.09 to $-0.05$393.0M↑0 ↓0
0y$-2.59$-4.29 to $-1.60$1.7B↑0 ↓0
+1q$-0.61$-1.14 to $-0.30$465.8M↑0 ↓0
+1y$0.13$-2.24 to $1.64$2.8B↑1 ↓0

Cross-Platform Signals

Insider Trades (90d)
0 buys / 5 sells
Congressional
Josh Gottheimer (democrat): sell $1,001 - $15,000
Institutional
Swedbank AB: add (56.3%)
Institutional
Assenagon Asset Management S.A.: doubled (245%)
Institutional
AMERIPRISE FINANCIAL INC: add (55.3%)
Short Interest
Short: 463,359 | Exempt: 0 | TRF Vol: 820,214 | Short Ratio: 56.5% | Off-exchange volume (dark pool + OTC)

Insider selling: C-suite members Lewis William (EVP) sold ~$1.26M on July 9 and Flammer Martina M.D. (likely C-suite) sold ~$1.35M on July 6, total $2.6M+ in insider sales. This is a bearish signal. Congressional activity: Rep. Josh Gottheimer (D) sold $1K-$15K on June 10, negligible. Institutional buying is strong: Ameriprise added 55.3% ($500M position), Assenagon doubled (+245%, $23.3M), Walleye Capital quadrupled (+354%, $11.7M). Short interest is 56.5% of TRF volume, elevated. The insider selling diverges from the bullish analyst signal, but institutional buying converges with it.

Investment Themes

Documents Analyzed

Report based on filing metadata.

Track record

24 reports on INSM

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +31.86% at T+60 after the Mar 30, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 3, 202613d ago 144 Neutral 2/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
  2. Nov 3, 202613d ago 3 Neutral 1/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
  3. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $111.59 Now $122.88 +10.12% settles Nov 27
  4. Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $94.04 Now $122.88 +30.67% settles Nov 18
  5. Oct 20, 202627d ago 8-K Neutral 3/10 Entry $95.67 Now $122.88 +28.44% settles Nov 17
  6. Oct 5, 20266w ago 8-K Neutral 4/10 Entry $103.83 to $112.58 Now $122.88 +18.35% ▲ +8.43% +10.89% vs SPY
  7. Aug 19, 202612w ago Insider Cluster Neutral 4/10 Entry $125.08 to $120.00 Now $122.88 −1.76% ▼ −4.06% −4.19% vs SPY
  8. Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $126.33 to $129.41 Now $122.88 −2.73% ▲ +2.44% +4.19% vs SPY
  9. Aug 6, 202614w ago 8-K Bullish 8/10 Entry $132.55 to $126.68 Now $122.88 −7.30% ▼ −4.43% −5.03% vs SPY
  10. Jul 24, 202616w ago Institutional Cluster Neutral 4/10 Entry $106.92 to $125.77 Now $122.88 +14.93% ▲ +17.63% +14.00% vs SPY
Showing 10 of 24

US Market Status

Market Closed · Opens Wed (10h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 21, 2026